SCHEMBL13675685

SCHEMBL13675685

COOCc1sc(-c2cccc(OC)c2)nc1Cl

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.50
TDP1 Q9NUW8 2/20 0.50
SMN1; SMN2 Q16637 2/20 0.50
NFKB1 P19838 1/20 0.50
RAB9A P51151 1/20 0.50
NFKB2 Q00653 1/20 0.50
RELA Q04206 1/20 0.50
KDM4E B2RXH2 2/20 0.47
LMNA P02545 1/20 0.47
ALDH1A1 P00352 2/20 0.42
TRPM8 Q7Z2W7 1/20 0.42
ADORA3 P0DMS8 1/20 0.41
ADORA2A P29274 1/20 0.41
ADORA1 P30542 1/20 0.41
CYP19A1 P11511 2/20 0.40
DCTPP1 Q9H773 1/20 0.40
USP2 O75604 1/20 0.40
HPGD P15428 1/20 0.40
HSD17B10 Q99714 1/20 0.40
PTGDR2 Q9Y5Y4 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13675569 0.84 ALOX5 (0.52) MAPTTDP1SMN1; SMN2RAB9AKDM4E
SCHEMBL13675568 0.84 L3MBTL1 (0.45) KDM4EALDH1A1TRPM8HPGDPTGDR2
SCHEMBL13675833 0.73 MAPT (0.42) MAPTTDP1SMN1; SMN2NFKB1RAB9A
SCHEMBL3825255 0.73 TRPM8 (0.52) MAPTTDP1SMN1; SMN2NFKB1RAB9A
SCHEMBL3372237 0.72 MAPT (0.55) MAPTTDP1SMN1; SMN2NFKB1RAB9A
SCHEMBL13462298 0.70 MAPT (0.51) MAPTTDP1SMN1; SMN2NFKB1RAB9A
SCHEMBL1180747 0.69 RAB9A (0.59) MAPTTDP1SMN1; SMN2NFKB1RAB9A
SCHEMBL8715461 0.68 CYP19A1 (0.59) MAPTTDP1SMN1; SMN2NFKB1RAB9A
SCHEMBL2090795 0.67 MAPT (1.00) MAPTTDP1SMN1; SMN2NFKB1RAB9A
SCHEMBL30161523 0.67 MAPT (1.00) MAPTTDP1SMN1; SMN2NFKB1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090270456-A1 Novel chemical compounds HASEGAWA MASAICHI 2009-10-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090270456-A1 Novel chemical compounds HIPK3, HIPK2, HIPK1 MAPT 1801/4885TDP1 1695/4885SMN1; SMN2 3016/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.